Development and Validation of a Prognostic Multivariable Model to Predict Insufficient Clinical Response to Methotrexate in Rheumatoid Arthritis

PLoS ONE - United States
doi 10.1371/journal.pone.0208534
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

IgG Fc Galactosylation Predicts Response to Methotrexate in Early Rheumatoid Arthritis

Arthritis Research & Therapy
2017English

The Development and Validation of a Multivariable Prognostic Model to Predict Foot Ulceration in Diabetes Using a Systematic Review and Individual Patient Data Meta-Analyses

Diabetic Medicine
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Thrombocytosis Development Due to the Use of Methotrexate in a Patient With Rheumatoid Arthritis

Rheumatology: Current Research
2018English

Prediction of Clinical Non-Response to Methotrexate Treatment in Juvenile Idiopathic Arthritis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2012English

Development and Validation of a Clinical Model to Predict Intraoperative Hemodynamic Instability in Patients With Pheochromocytomas Surgery

Endocrine Journal
EndocrinologyMetabolismDiabetes
2020English

Clinical Application of Transfer Factor to Juvenile Rheumatoid Arthritis and Rheumatoid Arthritis in a Adult

The KITAKANTO Medical Journal
1976English

Methotrexate+Medical Ozone Combined Therapy in Rheumatoid Arthritis. From Experimental Models to Clinical Trials [Abstract]

Journal of Ozone Therapy
2019English

FRI0040 Development and Validation of Clinical Predictors for Inadequate Response to Treat-To-Target Methotrexate Therapy in Newly Diagnosed Ra Patients

2018English

Peficitinib, a JAK Inhibitor, in the Treatment of Moderate-To-Severe Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy